Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration. The BRAMD study

MLA

Schauwvlieghe, A. M. E.(Ann-Sofie), et al. Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn963925858&authtype=sso&custid=ns315887.

APA

Schauwvlieghe, A. M. E. (Ann-S., Dijkman, G., Hooymans, J. M. M. (Johanna), Verbraak, F. D. (Frank), Hoyng, C. B. (Carel), Dijkgraaf, M. G. W. (Marcel), Peto, T. (Tünde), Vingerling, J. R. (Hans), & Schlingemann, R. O. (Reinier). (2016). Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration. The BRAMD study.

Chicago

Schauwvlieghe, A.M.E. (Ann-Sofie), G. Dijkman, J.M.M. (Johanna) Hooymans, F.D. (Frank) Verbraak, C.B. (Carel) Hoyng, M.G.W. (Marcel) Dijkgraaf, T. (Tünde) Peto, J.R. (Hans) Vingerling, and R.O. (Reinier) Schlingemann. 2016. “Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn963925858&authtype=sso&custid=ns315887.